Regeneron Pharmaceuticals Inc. Stock Falls Friday, Still Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) shed 2.44% to $659.11 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 3.63% to 4,131.93 and Dow Jones Industrial Average falling 2.77% to 32,977.21. Regeneron Pharmaceuticals Inc. closed $88.31 short of its 52-week high ($747.42), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 1.64% to $180.46, Novartis AG ADR (NOVN.EB) fell 2.43% to $88.03, and Amgen Inc. (AMGN) fell 2.07% to $233.19. Trading volume (678,106) eclipsed its 50-day average volume of 633,795.
Data source: Dow Jones Market Data, FactSet. Data compiled April 29, 2022.
-MarketWatch Automation
(END) Dow Jones Newswires
April 29, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.